MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Parkinson’s"

  • MDS Virtual Congress 2021

    Stratified genome-wide association study revealed novel interactions for the top hit Parkinson’s disease loci.

    K. Senkevich, S. Bandres-Ciga, E. Yu, L. Krohn, Z. Gan-Or (Montreal, Canada)

    Objective: To identify genetic modifiers and interactors that may modulate known risk variants in the SNCA, TMEM175 and MAPT loci in Parkinson’s disease (PD). Background:…
  • MDS Virtual Congress 2021

    Targeted plasmaproteome identifies a distinct biomarker panel in early and prodromal Parkinson’s disease

    M. Bartl, J. Hallqvist, M. Dakna, S. Schade, C. Trenkwalder, F. Sixel-Döring, B. Mollenhauer, K. Mills (Göttingen, Germany)

    Objective: To identify protein biomarkers in plasma of patients with Parkinson’s disease (PD). Background: Inflammation plays a key role in the initiation and progression of…
  • MDS Virtual Congress 2021

    PD phenotype with premotor RBD is associated with a dysbiotic profile of gut microbiota.

    V. Oppo, S. Vascellari, M. Melis, A. Manzin, G. Cossu (Cagliari, Italy)

    Objective: The aim of the study was to compare the fecal microbial composition of a group of PD patients with and without premotor RBD. Background:…
  • MDS Virtual Congress 2021

    Cerebral white matter atrophy may be associated with the performance of activities of daily livings in patients with Parkinson’s disease

    YK. Chen, ZH. Lu, XL. Fu (Dongguan, China)

    Objective: To assess whether global or regional brain structural abnormalities are associated performance of activities of daily livings (ADL) in patients with Parkinson's disease (PD).…
  • MDS Virtual Congress 2021

    Patterns of Cortical Thinning in Patients with Parkinson’s Disease

    H. Jergas, JC. Baldermann, JN. Petry-Schmelzer, H. Dafsari, V. Visser-Vanderwalle, T. Dembek, M. Barbe (Cologne, Germany)

    Objective: To investigate patterns of cortical thickness that are associated with disease severity and response to levodopa. Background: Cortex affection is a neuropathological correlate of…
  • MDS Virtual Congress 2021

    Relationship of subcortical iron deposition and mitochondrial dysfunction in patients with idiopathic Parkinson’s disease

    J. Prasuhn, M. Göttlich, F. Gerkan, S. Kourou, B. Ebeling, M. Kasten, H. Hanssen, C. Klein, N. Brüggemann (Lübeck, Germany)

    Objective: To investigate subcortical brain iron deposition as a potential predictor of the bioenergetic status in patients with idiopathic Parkinson's disease. Background: The underlying pathophysiology…
  • MDS Virtual Congress 2021

    Analysis of brain structural connectivity networks and white matter integrity in patients with early Parkinson’s disease: a longitudinal study

    R. Walsh, M. Bergamino, A. Stokes (Phoenix, USA)

    Objective: The objective of this study was to analyze the differences in structural connectivity and white matter (WM) microstructural integrity in people with early-PD over…
  • MDS Virtual Congress 2021

    Impact of the postural function сhanges on quality of life and daily activity in patients with Parkinson’s disease during DBS

    A. Buniak, S. Likhachev (Minsk, Belarus)

    Objective: Quality of life (QOL) and activity of daily living (ADL) in PD patients depends on the severity of motor disorders, including changes of postural…
  • MDS Virtual Congress 2021

    PARKINSON’S DISEASE AND COVID-19 PANDEMIC: MODIFICATIONS IN MOTOR AND NON-MOTOR SYMPTOMS AND IN THE ACCESS TO MEDICAL AND NON-MEDICAL CONSULTATIONS AND TREATMENTS

    J. Bestoso, C V. Stefani, L. Ciancaglini, D. Bauso (Buenos Aires, Argentina)

    Objective: The objective was to determine in a group of PD patients their perception of how isolation measures during the pandemic affected their motor and…
  • MDS Virtual Congress 2021

    Olfactory dysfunction in incidental Lewy body disease and Parkinson’s disease: An update

    S. Hasan, C. Adler, N. Zhang, G. Serrano, H. Shill, S. Mehta, T. Beach, E. Driver-Dunckley (Scottsdale, USA)

    Objective: Using a larger sample size compared to our previous study, we evaluated the relationship between olfactory dysfunction based on the University of Pennsylvania Smell…
  • « Previous Page
  • 1
  • …
  • 407
  • 408
  • 409
  • 410
  • 411
  • …
  • 436
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley